Free Trial

Voyager Therapeutics (VYGR) Competitors

Voyager Therapeutics logo
$4.17 -0.09 (-2.11%)
Closing price 03/10/2025 04:00 PM Eastern
Extended Trading
$4.25 +0.08 (+1.94%)
As of 03/10/2025 06:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VYGR vs. DAWN, RCKT, PHVS, CDMO, COGT, OCS, OPT, PRTA, MRVI, and CRON

Should you be buying Voyager Therapeutics stock or one of its competitors? The main competitors of Voyager Therapeutics include Day One Biopharmaceuticals (DAWN), Rocket Pharmaceuticals (RCKT), Pharvaris (PHVS), Avid Bioservices (CDMO), Cogent Biosciences (COGT), Oculis (OCS), Opthea (OPT), Prothena (PRTA), Maravai LifeSciences (MRVI), and Cronos Group (CRON). These companies are all part of the "pharmaceutical products" industry.

Voyager Therapeutics vs.

Day One Biopharmaceuticals (NASDAQ:DAWN) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

In the previous week, Day One Biopharmaceuticals had 7 more articles in the media than Voyager Therapeutics. MarketBeat recorded 11 mentions for Day One Biopharmaceuticals and 4 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 0.20 beat Day One Biopharmaceuticals' score of 0.12 indicating that Voyager Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Day One Biopharmaceuticals
3 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral
Voyager Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Voyager Therapeutics received 344 more outperform votes than Day One Biopharmaceuticals when rated by MarketBeat users. However, 69.33% of users gave Day One Biopharmaceuticals an outperform vote while only 67.81% of users gave Voyager Therapeutics an outperform vote.

CompanyUnderperformOutperform
Day One BiopharmaceuticalsOutperform Votes
52
69.33%
Underperform Votes
23
30.67%
Voyager TherapeuticsOutperform Votes
396
67.81%
Underperform Votes
188
32.19%

Voyager Therapeutics has a net margin of 15.80% compared to Day One Biopharmaceuticals' net margin of 0.00%. Voyager Therapeutics' return on equity of 8.33% beat Day One Biopharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Day One BiopharmaceuticalsN/A -22.40% -19.79%
Voyager Therapeutics 15.80%8.33%6.15%

87.9% of Day One Biopharmaceuticals shares are held by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are held by institutional investors. 8.4% of Day One Biopharmaceuticals shares are held by insiders. Comparatively, 4.5% of Voyager Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Voyager Therapeutics has higher revenue and earnings than Day One Biopharmaceuticals. Day One Biopharmaceuticals is trading at a lower price-to-earnings ratio than Voyager Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Day One Biopharmaceuticals$131.16M6.24-$188.92M-$1.08-7.47
Voyager Therapeutics$163.78M1.39$132.33M$0.715.87

Day One Biopharmaceuticals has a beta of -1.38, indicating that its share price is 238% less volatile than the S&P 500. Comparatively, Voyager Therapeutics has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500.

Day One Biopharmaceuticals presently has a consensus price target of $34.57, indicating a potential upside of 328.39%. Voyager Therapeutics has a consensus price target of $15.72, indicating a potential upside of 276.89%. Given Day One Biopharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Day One Biopharmaceuticals is more favorable than Voyager Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Day One Biopharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13
Voyager Therapeutics
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.11

Summary

Voyager Therapeutics beats Day One Biopharmaceuticals on 11 of the 18 factors compared between the two stocks.

Remove Ads
Get Voyager Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VYGR vs. The Competition

MetricVoyager TherapeuticsBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$227.79M$3.12B$5.72B$8.00B
Dividend YieldN/A1.47%4.89%4.03%
P/E Ratio5.8728.5624.9018.90
Price / Sales1.39364.24401.45115.03
Price / Cash1.41168.6838.0534.62
Price / Book0.783.387.274.15
Net Income$132.33M-$71.72M$3.19B$246.75M
7 Day Performance6.65%-2.38%-0.85%-2.17%
1 Month Performance-21.62%-11.33%-6.83%-9.12%
1 Year Performance-55.50%-25.09%11.07%-0.27%

Voyager Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VYGR
Voyager Therapeutics
4.1229 of 5 stars
$4.17
-2.1%
$15.72
+276.9%
-55.5%$227.79M$163.78M5.87100
DAWN
Day One Biopharmaceuticals
2.5165 of 5 stars
$8.25
-8.9%
$34.86
+322.5%
-48.1%$836.18M$131.16M-8.0160High Trading Volume
RCKT
Rocket Pharmaceuticals
4.6432 of 5 stars
$8.79
-7.0%
$42.30
+381.2%
-69.2%$801.27MN/A-3.20240
PHVS
Pharvaris
1.7277 of 5 stars
$15.32
-3.6%
$40.50
+164.4%
-43.7%$801.08MN/A-5.4730Gap Up
CDMO
Avid Bioservices
1.0013 of 5 stars
$12.50
+0.1%
$12.25
-2.0%
+86.2%$799.18M$139.91M-5.23320High Trading Volume
COGT
Cogent Biosciences
2.0706 of 5 stars
$7.00
-7.0%
$14.00
+100.0%
+3.9%$796.95MN/A-2.8280Analyst Forecast
Gap Down
OCS
Oculis
1.9571 of 5 stars
$19.54
-0.2%
$28.80
+47.4%
+57.6%$791.45M$980,000.00-10.122Upcoming Earnings
OPT
Opthea
1.9521 of 5 stars
$5.11
+14.1%
$12.00
+134.8%
-2.7%$786.47M$124,666.000.008High Trading Volume
PRTA
Prothena
2.8575 of 5 stars
$14.33
-9.4%
$55.00
+283.8%
-51.7%$771.08M$135.16M-6.23130
MRVI
Maravai LifeSciences
3.8178 of 5 stars
$3.02
-6.2%
$9.28
+207.3%
-62.7%$762.64M$276.92M-1.84610News Coverage
CRON
Cronos Group
1.6735 of 5 stars
$1.97
-3.9%
$3.00
+52.3%
-3.0%$753.59M$117.62M-15.15450
Remove Ads

Related Companies and Tools


This page (NASDAQ:VYGR) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners